Medizinische Universität Graz - Research portal

• Go directly to the nagivation.
• Go directly to the content.

• Print view.
• German.
• Contact.
• Data entry.
• Start.
• Open Access.

Identifying novel targets to combat aberrant TP53 mediated therapeutic resistance in acute myeloid leukemia using CRISPRko screens

Project Leader:

Dutta Sayantanee

Duration:

01.02.2024-31.07.2026

Type of Research

basic research

Staff

Dutta, Sayantanee, Project Leader

Kleinrath, Christoph, Co-worker

MUG Research Units

Division of Oncology

Funded by

Gilead Sciences, 2 Roundwood Avenue , South Building, Stockley Park, Uxbridge, UB11 1AF Middlesex, United Kingdom